Hetlioz - bulk
Ended Awarded Last action
- Contract number
- 36C26025F0002
- Awardee
-
Vanda Pharmaceuticals Inc. UEI NG5JU1TQ3379
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $131,068
Award facts
- Contract value 100% obligated
- $131,067.77 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Bartlett, TN 38134, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$31,703 | |
| Original award | $162,771 |
About this award
Vanda Pharmaceuticals Inc. has been awarded a delivery order valued at $131,067.77 by Veterans Integrated Service Network 20 (VISN 20), a civilian agency within the Department of Veterans Affairs. This firm fixed-price contract is for the supply of HETLIOZ (tasimelteon) in bulk, a specialized pharmaceutical used to treat Non-24-Hour Sleep-Wake Disorder in blind adults and patients with Smith-Magenis Syndrome. The delivery order is set to be completed by September 30, 2025, with performance occurring in Bartlett, Tennessee. This award is not designated as a set-aside and is issued under the Pharmaceuticals and Drugs GSA Schedule (FSS-61-IB), through which Vanda maintains multiple standing agreements to supply pharmaceutical products to VA facilities nationwide.
Vanda Pharmaceuticals, headquartered in Washington, DC, is an established biopharmaceutical manufacturer with a significant track record of supplying specialized medications to the VA system since its registration in SAM.gov in 2011. This delivery order represents part of the company's broader federal contract portfolio with the VA, which includes multiple Indefinite Delivery Vehicles with combined ceiling values exceeding $22 million through 2029. The award supports the VA's mission to provide targeted pharmaceutical solutions to veterans with specialized medical needs, leveraging Vanda's expertise as a primary supplier of HETLIOZ products across multiple Veterans Integrated Service Networks.
Quick answers
Who was awarded contract 36C26025F0002?
36C26025F0002 was awarded to Vanda Pharmaceuticals Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on October 1, 2024.
How much is contract 36C26025F0002 worth?
The government has obligated $131,068 on 36C26025F0002.
Is contract 36C26025F0002 an order under another contract?
Yes. 36C26025F0002 is a delivery order under V797D70102, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26025F0002 competed?
The extent of competition for 36C26025F0002 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award